Most schizophrenia treatment guidelines recommend against using antipsychotic polypharmacy, or using it only as a last resort.
Not exact matches
The ability to shut out stimuli could also turn nicotine into a
treatment for
schizophrenia, where afflicted individuals are overwhelmed by sights, sounds and thoughts that
most of us would either ignore or quickly dismiss.
People with
schizophrenia may now benefit from more effective, tailored
treatments and greater self - empowerment, thanks to research establishing a link between childhood trauma and some of
schizophrenia's
most common symptoms.
«Childhood trauma link offers
treatment hope for people with
schizophrenia: People with
schizophrenia may now benefit from more effective, tailored
treatments and greater self - empowerment, thanks to research establishing a link between childhood trauma and some of
schizophrenia's
most common symptoms..»
Unlike
most treatments for
schizophrenia — such as medication to subdue delusions — this program was designed to address the condition's «negative» traits, those that
most resemble autism.
Perhaps the
most valuable takeaway from comparing autism and
schizophrenia's social features would be better
treatment.
The discovery of specialist stem cells responsible for our
most advanced cognition could pave the way for new
treatments for autism and
schizophrenia
«GlyT - 1 inhibition was one of the
most promising approaches to the
treatment of
schizophrenia,» said Krystal.
Most recently, they have shown that by pharmacologically restoring NMDAR function in these «schizophrenic» mice, their structural, neurochemical, and cognitive deficits can be reversed, pointing to new strategies for more effective
treatments for
schizophrenia and potentially other serious mental illnesses.
Most of our current treatments for the most commonplace Axis I disorders in psychiatry (depression, schizophrenia and bipolar disorder) induce mitochondrial dysfunction, Increase insulin resistance, and promote obesity, and type II diabe
Most of our current
treatments for the
most commonplace Axis I disorders in psychiatry (depression, schizophrenia and bipolar disorder) induce mitochondrial dysfunction, Increase insulin resistance, and promote obesity, and type II diabe
most commonplace Axis I disorders in psychiatry (depression,
schizophrenia and bipolar disorder) induce mitochondrial dysfunction, Increase insulin resistance, and promote obesity, and type II diabetes.
More than 50 randomised control trials of FPE in the
treatment of
schizophrenia have been conducted over the last 35 years with the
most consistent findings showing significant reductions in relapse and hospital admission rates.
Since CJS involvement among people with
schizophrenia was
most strongly associated with drug abuse,
treatment of co-morbid drug abuse could reduce the risk of stigma, pain, and other adverse consequences of CJS involvement as well as save CJS expenditures.